{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T17:39:52Z","timestamp":1794850792270,"version":"4.9.1"},"reference-count":104,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T00:00:00Z","timestamp":1726099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T00:00:00Z","timestamp":1726099200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institutes of Allergy and Infectious Diseases","doi-asserted-by":"crossref","award":["R21AI151736"],"award-info":[{"award-number":["R21AI151736"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-024-09870-4","type":"journal-article","created":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T18:02:43Z","timestamp":1726164163000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Hepatitis E virus immunosuppressed animal models"],"prefix":"10.1186","volume":"24","author":[{"given":"Kush Kumar","family":"Yadav","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott P.","family":"Kenney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,12]]},"reference":[{"key":"9870_CR1","doi-asserted-by":"crossref","unstructured":"Grange ZL, Goldstein T, Johnson CK, Anthony S, Gilardi K, Daszak P et al. Ranking the risk of animal-to-human spillover for newly discovered viruses. Proceedings of the National Academy of Sciences. 2021;118(15):e2002324118.","DOI":"10.1073\/pnas.2115409118"},{"key":"9870_CR2","doi-asserted-by":"crossref","unstructured":"Lhomme S, Marion O, Abravanel F, Izopet J, Kamar N. Clinical manifestations, Pathogenesis and treatment of Hepatitis E Virus infections. J Clin Med. 2020;9(2).","DOI":"10.3390\/jcm9020331"},{"issue":"8","key":"9870_CR3","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1056\/NEJMoa0706992","volume":"358","author":"N Kamar","year":"2008","unstructured":"Kamar N, Selves J, Mansuy JM, Ouezzani L, P\u00e9ron JM, Guitard J, et al. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl J Med. 2008;358(8):811\u20137.","journal-title":"N Engl J Med"},{"issue":"6","key":"9870_CR4","doi-asserted-by":"publisher","first-page":"430","DOI":"10.7326\/0003-4819-150-6-200903170-00026","volume":"150","author":"L Ollier","year":"2009","unstructured":"Ollier L, Tieulie N, Sanderson F, Heudier P, Giordanengo V, Fuzibet JG, et al. Chronic hepatitis after hepatitis E virus infection in a patient with non-hodgkin lymphoma taking rituximab. Ann Intern Med. 2009;150(6):430\u20131.","journal-title":"Ann Intern Med"},{"issue":"10","key":"9870_CR5","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1056\/NEJMc0903778","volume":"361","author":"HR Dalton","year":"2009","unstructured":"Dalton HR, Bendall RP, Keane FE, Tedder RS, Ijaz S. Persistent carriage of hepatitis E virus in patients with HIV infection. N Engl J Med. 2009;361(10):1025\u20137.","journal-title":"N Engl J Med"},{"key":"9870_CR6","doi-asserted-by":"publisher","first-page":"577339","DOI":"10.3389\/fmicb.2020.577339","volume":"11","author":"V Thakur","year":"2020","unstructured":"Thakur V, Ratho RK, Kumar S, Saxena SK, Bora I, Thakur P. Viral Hepatitis E and chronicity: a growing Public Health concern. Front Microbiol. 2020;11:577339.","journal-title":"Front Microbiol"},{"key":"9870_CR7","doi-asserted-by":"crossref","unstructured":"Thongprayoon C, Kaewput W, Pattharanitima P, Cheungpasitporn W. Progress and recent advances in solid organ transplantation. J Clin Med. 2022;11(8).","DOI":"10.3390\/jcm11082112"},{"issue":"1","key":"9870_CR8","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/0042-6822(91)90760-9","volume":"185","author":"AW Tam","year":"1991","unstructured":"Tam AW, Smith MM, Guerra ME, Huang CC, Bradley DW, Fry KE, et al. Hepatitis E virus (HEV): molecular cloning and sequencing of the full-length viral genome. Virology. 1991;185(1):120\u201331.","journal-title":"Virology"},{"issue":"12","key":"9870_CR9","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.3201\/eid2412.180937","volume":"24","author":"S Sridhar","year":"2018","unstructured":"Sridhar S, Yip CCY, Wu S, Cai J, Zhang AJ, Leung KH, et al. Rat Hepatitis E Virus as cause of Persistent Hepatitis after Liver Transplant. Emerg Infect Dis. 2018;24(12):2241\u201350.","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"9870_CR10","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/hep.31138","volume":"73","author":"S Sridhar","year":"2021","unstructured":"Sridhar S, Yip CC, Wu S, Chew NF, Leung KH, Chan JF, et al. Transmission of Rat Hepatitis E virus infection to humans in Hong Kong: a clinical and epidemiological analysis. Hepatology (Baltimore MD). 2021;73(1):10\u201322.","journal-title":"Hepatology (Baltimore MD)"},{"issue":"4","key":"9870_CR11","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1002\/lt.21480","volume":"14","author":"EB Haagsma","year":"2008","unstructured":"Haagsma EB, van den Berg AP, Porte RJ, Benne CA, Vennema H, Reimerink JH, et al. Chronic hepatitis E virus infection in liver transplant recipients. Liver transplantation: official publication of the American Association for the study of Liver diseases. Int Liver Transplantation Soc. 2008;14(4):547\u201353.","journal-title":"Int Liver Transplantation Soc"},{"issue":"2","key":"9870_CR12","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1053\/j.gastro.2015.10.048","volume":"150","author":"GH Lee","year":"2016","unstructured":"Lee GH, Tan BH, Teo EC, Lim SG, Dan YY, Wee A, et al. Chronic infection with Camelid Hepatitis E Virus in a liver transplant recipient who regularly consumes Camel meat and milk. Gastroenterology. 2016;150(2):355\u2013e73.","journal-title":"Gastroenterology"},{"key":"9870_CR13","doi-asserted-by":"crossref","unstructured":"Shirazi R, Pozzi P, Gozlan Y, Wax M, Lustig Y, Linial M et al. Identification of Hepatitis E virus genotypes 3 and 7 in Israel. Public Health Concern? Viruses. 2021;13(11).","DOI":"10.3390\/v13112326"},{"issue":"5","key":"9870_CR14","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1136\/gutjnl-2019-319004","volume":"69","author":"O Marion","year":"2020","unstructured":"Marion O, Lhomme S, Nayrac M, Dubois M, Pucelle M, Requena M, et al. Hepatitis E virus replication in human intestinal cells. Gut. 2020;69(5):901\u201310.","journal-title":"Gut"},{"issue":"1","key":"9870_CR15","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1128\/CMR.00057-13","volume":"27","author":"N Kamar","year":"2014","unstructured":"Kamar N, Dalton HR, Abravanel F, Izopet J. Hepatitis E virus infection. Clin Microbiol Rev. 2014;27(1):116\u201338.","journal-title":"Clin Microbiol Rev"},{"issue":"8","key":"9870_CR16","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1056\/NEJMc0708687","volume":"358","author":"R G\u00e9rolami","year":"2008","unstructured":"G\u00e9rolami R, Moal V, Colson P. Chronic hepatitis E with cirrhosis in a kidney-transplant recipient. N Engl J Med. 2008;358(8):859\u201360.","journal-title":"N Engl J Med"},{"issue":"7","key":"9870_CR17","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1111\/ajt.12253","volume":"13","author":"N Kamar","year":"2013","unstructured":"Kamar N, Rostaing L, Legrand-Abravanel F, Izopet J. How should Hepatitis E virus infection be defined in organ-transplant recipients? Am J Transplantation: Official J Am Soc Transplantation Am Soc Transpl Surg. 2013;13(7):1935\u20136.","journal-title":"Am J Transplantation: Official J Am Soc Transplantation Am Soc Transpl Surg"},{"issue":"5","key":"9870_CR18","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1053\/j.gastro.2011.02.050","volume":"140","author":"N Kamar","year":"2011","unstructured":"Kamar N, Garrouste C, Haagsma EB, Garrigue V, Pischke S, Chauvet C, et al. Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants. Gastroenterology. 2011;140(5):1481\u20139.","journal-title":"Gastroenterology"},{"issue":"6","key":"9870_CR19","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1086\/655899","volume":"202","author":"F Legrand-Abravanel","year":"2010","unstructured":"Legrand-Abravanel F, Kamar N, Sandres-Saune K, Garrouste C, Dubois M, Mansuy JM, et al. Characteristics of autochthonous hepatitis E virus infection in solid-organ transplant recipients in France. J Infect Dis. 2010;202(6):835\u201344.","journal-title":"J Infect Dis"},{"issue":"11","key":"9870_CR20","doi-asserted-by":"publisher","first-page":"3128","DOI":"10.1111\/j.1600-6143.2012.04200.x","volume":"12","author":"S Pischke","year":"2012","unstructured":"Pischke S, Stiefel P, Franz B, Bremer B, Suneetha PV, Heim A, et al. Chronic hepatitis e in heart transplant recipients. Am J Transplantation: Official J Am Soc Transplantation Am Soc Transpl Surg. 2012;12(11):3128\u201333.","journal-title":"Am J Transplantation: Official J Am Soc Transplantation Am Soc Transpl Surg"},{"issue":"10","key":"9870_CR21","first-page":"1225","volume":"15","author":"EB Haagsma","year":"2009","unstructured":"Haagsma EB, Niesters HG, van den Berg AP, Riezebos-Brilman A, Porte RJ, Vennema H, et al. Prevalence of hepatitis E virus infection in liver transplant recipients. Liver transplantation: official publication of the American Association for the Study of Liver Diseases and the International Liver. Transplantation Soc. 2009;15(10):1225\u20138.","journal-title":"Transplantation Soc"},{"issue":"5","key":"9870_CR22","doi-asserted-by":"publisher","first-page":"941","DOI":"10.3201\/eid2405.171845","volume":"24","author":"C Charre","year":"2018","unstructured":"Charre C, Rami\u00e8re C, Dumortier J, Abravanel F, Lhomme S, Gincul R, et al. Chronic genotype 3 Hepatitis E in pregnant woman receiving infliximab and azathioprine. Emerg Infect Dis. 2018;24(5):941\u20133.","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"9870_CR23","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.jcv.2013.09.023","volume":"58","author":"V Mallet","year":"2013","unstructured":"Mallet V, Le Mener S, Roque-Afonso AM, Tsatsaris V, Mamzer MF. Chronic hepatitis E infection cured by pregnancy. J Clin Virology: Official Publication Pan Am Soc Clin Virol. 2013;58(4):745\u20137.","journal-title":"J Clin Virology: Official Publication Pan Am Soc Clin Virol"},{"issue":"6","key":"9870_CR24","doi-asserted-by":"publisher","first-page":"e1634","DOI":"10.1097\/TXD.0000000000001634","volume":"10","author":"O Marion","year":"2024","unstructured":"Marion O, Abravanel F, Conan L, Dubucs C, Danjoux M, Izopet J, et al. Hepatitis E virus infection in a pregnant liver transplant recipient leading to chronic infection. Transplantation Direct. 2024;10(6):e1634.","journal-title":"Transplantation Direct"},{"issue":"10","key":"9870_CR25","doi-asserted-by":"publisher","first-page":"O718","DOI":"10.1111\/1469-0691.12576","volume":"20","author":"J Ambrosioni","year":"2014","unstructured":"Ambrosioni J, Mamin A, Hadengue A, Bernimoulin M, Samii K, Landelle C, et al. Long-term hepatitis E viral load kinetics in an immunocompromised patient treated with Ribavirin. Clin Microbiol Infection: Official Publication Eur Soc Clin Microbiol Infect Dis. 2014;20(10):O718\u201320.","journal-title":"Clin Microbiol Infection: Official Publication Eur Soc Clin Microbiol Infect Dis"},{"issue":"1","key":"9870_CR26","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1093\/cid\/ciu742","volume":"60","author":"F Abravanel","year":"2015","unstructured":"Abravanel F, Lhomme S, Rostaing L, Kamar N, Izopet J. Protracted fecal shedding of HEV during Ribavirin therapy predicts treatment relapse. Clin Infect Diseases: Official Publication Infect Dis Soc Am. 2015;60(1):96\u20139.","journal-title":"Clin Infect Diseases: Official Publication Infect Dis Soc Am"},{"issue":"1","key":"9870_CR27","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.jhep.2018.09.011","volume":"70","author":"O Marion","year":"2019","unstructured":"Marion O, Lhomme S, Del Bello A, Abravanel F, Esposito L, H\u00e9bral AL, et al. Monitoring hepatitis E virus fecal shedding to optimize Ribavirin treatment duration in chronically infected transplant patients. J Hepatol. 2019;70(1):206\u20139.","journal-title":"J Hepatol"},{"issue":"3","key":"9870_CR28","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.jinf.2019.01.004","volume":"78","author":"O Marion","year":"2019","unstructured":"Marion O, Capelli N, Lhomme S, Dubois M, Pucelle M, Abravanel F, et al. Hepatitis E virus genotype 3 and capsid protein in the blood and urine of immunocompromised patients. J Infect. 2019;78(3):232\u201340.","journal-title":"J Infect"},{"issue":"2","key":"9870_CR29","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/jgh.14405","volume":"34","author":"H Zhang","year":"2019","unstructured":"Zhang H, Rao H, Wang Y, Wang J, Kong X, Ji Y, et al. Evaluation of an antigen assay for diagnosing acute and chronic hepatitis E genotype 4 infection. J Gastroenterol Hepatol. 2019;34(2):458\u201365.","journal-title":"J Gastroenterol Hepatol"},{"issue":"8","key":"9870_CR30","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1111\/j.1600-6143.2008.02286.x","volume":"8","author":"N Kamar","year":"2008","unstructured":"Kamar N, Mansuy JM, Cointault O, Selves J, Abravanel F, Danjoux M, et al. Hepatitis E virus-related cirrhosis in kidney- and kidney-pancreas-transplant recipients. Am J Transplantation: Official J Am Soc Transplantation Am Soc Transpl Surg. 2008;8(8):1744\u20138.","journal-title":"Am J Transplantation: Official J Am Soc Transplantation Am Soc Transpl Surg"},{"issue":"3","key":"9870_CR31","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","volume":"18","author":"T Kisseleva","year":"2021","unstructured":"Kisseleva T, Brenner D. Molecular and cellular mechanisms of liver fibrosis and its regression. Nat Reviews Gastroenterol Hepatol. 2021;18(3):151\u201366.","journal-title":"Nat Reviews Gastroenterol Hepatol"},{"issue":"1","key":"9870_CR32","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/lt.21958","volume":"16","author":"S Pischke","year":"2010","unstructured":"Pischke S, Suneetha PV, Baechlein C, Barg-Hock H, Heim A, Kamar N, et al. Hepatitis E virus infection as a cause of graft hepatitis in liver transplant recipients. Liver transplantation: official publication of the American Association for the study of Liver diseases. Int Liver Transplantation Soc. 2010;16(1):74\u201382.","journal-title":"Int Liver Transplantation Soc"},{"issue":"4","key":"9870_CR33","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/liv.13037","volume":"36","author":"N Kamar","year":"2016","unstructured":"Kamar N, Marion O, Abravanel F, Izopet J, Dalton HR. Extrahepatic manifestations of hepatitis E virus. Liver International: Official J Int Association Study Liver. 2016;36(4):467\u201372.","journal-title":"Liver International: Official J Int Association Study Liver"},{"issue":"3","key":"9870_CR34","doi-asserted-by":"publisher","first-page":"482","DOI":"10.4254\/wjh.v14.i3.482","volume":"14","author":"K Damiris","year":"2022","unstructured":"Damiris K, Aghaie Meybodi M, Niazi M, Pyrsopoulos N. Hepatitis E in immunocompromised individuals. World J Hepatol. 2022;14(3):482\u201394.","journal-title":"World J Hepatol"},{"key":"9870_CR35","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.2147\/IDR.S449221","volume":"17","author":"R Alexandrova","year":"2024","unstructured":"Alexandrova R, Tsachev I, Kirov P, Abudalleh A, Hristov H, Zhivkova T, et al. Hepatitis E Virus (HEV) infection among immunocompromised individuals: a brief narrative review. Infect drug Resist. 2024;17:1021\u201340.","journal-title":"Infect drug Resist"},{"issue":"7","key":"9870_CR36","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1128\/JCM.02295-07","volume":"46","author":"P Colson","year":"2008","unstructured":"Colson P, Payraudeau E, Leonnet C, De Montigny S, Villeneuve L, Motte A, et al. Severe thrombocytopenia associated with acute hepatitis E virus infection. J Clin Microbiol. 2008;46(7):2450\u20132.","journal-title":"J Clin Microbiol"},{"key":"9870_CR37","doi-asserted-by":"crossref","unstructured":"Fourquet E, Mansuy JM, Bureau C, Recher C, Vinel JP, Izopet J et al. Severe thrombocytopenia associated with acute autochthonous hepatitis E. Journal of clinical virology: the official publication of the Pan American Society for Clinical Virology. 2010;48(1):73\u20134.","DOI":"10.1016\/j.jcv.2010.02.016"},{"issue":"4","key":"9870_CR38","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.jhep.2022.05.006","volume":"77","author":"Z Ma","year":"2022","unstructured":"Ma Z, de Man RA, Kamar N, Pan Q. Chronic hepatitis E: advancing research and patient care. J Hepatol. 2022;77(4):1109\u201323.","journal-title":"J Hepatol"},{"key":"9870_CR39","doi-asserted-by":"crossref","unstructured":"Pischke S, Peron JM, von Wulffen M, von Felden J, H\u00f6ner Zu Siederdissen C, Fournier S et al. Chronic Hepatitis E in Rheumatology and Internal Medicine patients: a Retrospective Multicenter European Cohort Study. Viruses. 2019;11(2).","DOI":"10.3390\/v11020186"},{"issue":"12","key":"9870_CR40","doi-asserted-by":"publisher","first-page":"2870","DOI":"10.3324\/haematol.2022.280853","volume":"107","author":"S Ghandili","year":"2022","unstructured":"Ghandili S, Lindhauer C, Pischke S, Zur Wiesch JS, Von Kroge PH, Polywka S, et al. Clinical features of hepatitis E infections in patients with hematologic disorders. Haematologica. 2022;107(12):2870\u201383.","journal-title":"Haematologica"},{"key":"9870_CR41","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.3389\/fmicb.2019.01425","volume":"10","author":"A Rivero-Juarez","year":"2019","unstructured":"Rivero-Juarez A, Lopez-Lopez P, Frias M, Rivero A. Hepatitis E infection in HIV-Infected patients. Front Microbiol. 2019;10:1425.","journal-title":"Front Microbiol"},{"key":"9870_CR42","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jcv.2019.08.002","volume":"119","author":"S Cruz","year":"2019","unstructured":"Cruz S, Campos C, Tim\u00f3teo M, Tavares A, Jos\u00e9 Nascimento MS, Medeiros R, et al. Hepatitis E virus in hematopoietic stem cell transplant recipients: a systematic review. J Clin Virol. 2019;119:31\u20136.","journal-title":"J Clin Virol"},{"issue":"22","key":"9870_CR43","doi-asserted-by":"publisher","first-page":"3846","DOI":"10.1182\/blood.V128.22.3846.3846","volume":"128","author":"R Ian","year":"2016","unstructured":"Ian R, Fox T, Irish D, Bharucha T, Thorburn D, Mark H, et al. Hepatitis E Viraemia in Transplant recipients. Blood. 2016;128(22):3846.","journal-title":"Blood"},{"issue":"7","key":"9870_CR44","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1038\/s41409-020-0823-7","volume":"55","author":"L Swartling","year":"2020","unstructured":"Swartling L, Nord\u00e9n R, Samuelsson E, Boriskina K, Valentini D, Westin J, et al. Hepatitis E virus is an infrequent but potentially serious infection in allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transplant. 2020;55(7):1255\u201363.","journal-title":"Bone Marrow Transplant"},{"key":"9870_CR45","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/164_2021_544","volume":"272","author":"TF Michniacki","year":"2022","unstructured":"Michniacki TF, Choi SW, Peltier DC. Immune suppression in allogeneic hematopoietic stem cell transplantation. Handb Exp Pharmacol. 2022;272:209\u201343.","journal-title":"Handb Exp Pharmacol"},{"issue":"3","key":"9870_CR46","doi-asserted-by":"publisher","first-page":"e0174070","DOI":"10.1371\/journal.pone.0174070","volume":"12","author":"NR Gardinali","year":"2017","unstructured":"Gardinali NR, Guimar\u00e3es JR, Melga\u00e7o JG, Kevorkian YB, Bottino FO, Vieira YR, et al. Cynomolgus monkeys are successfully and persistently infected with hepatitis E virus genotype 3 (HEV-3) after long-term immunosuppressive therapy. PLoS ONE. 2017;12(3):e0174070.","journal-title":"PLoS ONE"},{"key":"9870_CR47","doi-asserted-by":"crossref","unstructured":"Cao D, Cao QM, Subramaniam S, Yugo DM, Heffron CL, Rogers AJ et al. Pig model mimicking chronic hepatitis E virus infection in immunocompromised patients to assess immune correlates during chronicity. Proceedings of the National Academy of Sciences. 2017;114(27):6914-23.","DOI":"10.1073\/pnas.1705446114"},{"key":"9870_CR48","doi-asserted-by":"crossref","unstructured":"Le\u00f3n-Janampa N, Caballero-Posadas I, Barc C, Darrouzain F, Moreau A, Guinoiseau T et al. A pig model of chronic hepatitis E displaying persistent viremia and a downregulation of innate immune responses in the liver. Hepatol Commun. 2023;7(11).","DOI":"10.1097\/HC9.0000000000000274"},{"key":"9870_CR49","doi-asserted-by":"crossref","unstructured":"He Q, Zhang F, Shu J, Li S, Liang Z, Du M, et al. Immunocompromised rabbit model of chronic HEV reveals liver fibrosis and distinct efficacy of different vaccination strategies. Hepatology (Baltimore, Md; 2022.","DOI":"10.1002\/hep.32455"},{"key":"9870_CR50","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/1471-2334-9-93","volume":"9","author":"F Huang","year":"2009","unstructured":"Huang F, Zhang W, Gong G, Yuan C, Yan Y, Yang S, et al. Experimental infection of Balb\/c nude mice with Hepatitis E virus. BMC Infect Dis. 2009;9:93.","journal-title":"BMC Infect Dis"},{"issue":"5","key":"9870_CR51","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.jhep.2016.01.011","volume":"64","author":"L Allweiss","year":"2016","unstructured":"Allweiss L, Gass S, Giersch K, Groth A, Kah J, Volz T, et al. Human liver chimeric mice as a new model of chronic hepatitis E virus infection and preclinical drug evaluation. J Hepatol. 2016;64(5):1033\u201340.","journal-title":"J Hepatol"},{"key":"9870_CR52","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.3389\/fmicb.2020.01156","volume":"11","author":"Y Li","year":"2020","unstructured":"Li Y, Long F, Yang C, Hao X, Wu J, Situ J, et al. BALB\/c mouse is a potential animal Model System for studying Acute and Chronic Genotype 4 Hepatitis E virus infection. Front Microbiol. 2020;11:1156.","journal-title":"Front Microbiol"},{"key":"9870_CR53","doi-asserted-by":"publisher","first-page":"819877","DOI":"10.3389\/fmicb.2022.819877","volume":"13","author":"L Collignon","year":"2022","unstructured":"Collignon L, Verhoye L, Hakze-Van der Honing R, Van der Poel WHM, Meuleman P. Study of Hepatitis E Virus-4 infection in human Liver-Chimeric, Immunodeficient, and Immunocompetent mice. Front Microbiol. 2022;13:819877.","journal-title":"Front Microbiol"},{"issue":"10","key":"9870_CR54","doi-asserted-by":"publisher","first-page":"100546","DOI":"10.1016\/j.jhepr.2022.100546","volume":"4","author":"S Sridhar","year":"2022","unstructured":"Sridhar S, Wu S, Situ J, Shun EH, Li Z, Zhang AJ, et al. A small animal model of chronic hepatitis E infection using immunocompromised rats. JHEP Rep. 2022;4(10):100546.","journal-title":"JHEP Rep"},{"issue":"9","key":"9870_CR55","doi-asserted-by":"publisher","first-page":"e1011664","DOI":"10.1371\/journal.ppat.1011664","volume":"19","author":"S Subramaniam","year":"2023","unstructured":"Subramaniam S, Fares-Gusmao R, Sato S, Cullen JM, Takeda K, Farci P, et al. Distinct disease features of acute and persistent genotype 3 hepatitis E virus infection in immunocompetent and immunosuppressed Mongolian gerbils. PLoS Pathog. 2023;19(9):e1011664.","journal-title":"PLoS Pathog"},{"issue":"1","key":"9870_CR56","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.virusres.2011.03.007","volume":"161","author":"K Krawczynski","year":"2011","unstructured":"Krawczynski K, Meng XJ, Rybczynska J. Pathogenetic elements of hepatitis E and animal models of HEV infection. Virus Res. 2011;161(1):78\u201383.","journal-title":"Virus Res"},{"issue":"3","key":"9870_CR57","first-page":"e9","volume":"2","author":"RH Purcell","year":"2013","unstructured":"Purcell RH, Engle RE, Govindarajan S, Herbert R, St Claire M, Elkins WR, et al. Pathobiology of hepatitis E: lessons learned from primate models. Emerg Microbes Infections. 2013;2(3):e9.","journal-title":"Emerg Microbes Infections"},{"issue":"21","key":"9870_CR58","doi-asserted-by":"publisher","first-page":"10198","DOI":"10.1073\/pnas.91.21.10198","volume":"91","author":"SA Tsarev","year":"1994","unstructured":"Tsarev SA, Tsareva TS, Emerson SU, Govindarajan S, Shapiro M, Gerin JL, et al. Successful passive and active immunization of cynomolgus monkeys against hepatitis E. Proc Natl Acad Sci U S A. 1994;91(21):10198\u2013202.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"9870_CR59","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/jmv.1890430207","volume":"43","author":"SA Tsarev","year":"1994","unstructured":"Tsarev SA, Tsareva TS, Emerson SU, Yarbough PO, Legters LJ, Moskal T, et al. Infectivity titration of a prototype strain of hepatitis E virus in cynomolgus monkeys. J Med Virol. 1994;43(2):135\u201342.","journal-title":"J Med Virol"},{"issue":"1","key":"9870_CR60","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1159\/000149370","volume":"20","author":"MS Balayan","year":"1983","unstructured":"Balayan MS, Andjaparidze AG, Savinskaya SS, Ketiladze ES, Braginsky DM, Savinov AP, et al. Evidence for a virus in non-A, non-B hepatitis transmitted via the fecal-oral route. Intervirology. 1983;20(1):23\u201331.","journal-title":"Intervirology"},{"issue":"4","key":"9870_CR61","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1254\/jphs.08142FP","volume":"108","author":"F Kinugasa","year":"2008","unstructured":"Kinugasa F, Nagatomi I, Ishikawa H, Nakanishi T, Maeda M, Hirose J, et al. Efficacy of oral treatment with tacrolimus in the renal transplant model in cynomolgus monkeys. J Pharmacol Sci. 2008;108(4):529\u201334.","journal-title":"J Pharmacol Sci"},{"issue":"2","key":"9870_CR62","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1093\/ilar.49.2.209","volume":"49","author":"SV Haustein","year":"2008","unstructured":"Haustein SV, Kolterman AJ, Sundblad JJ, Fechner JH, Knechtle SJ. Nonhuman primate infections after organ transplantation. ILAR J. 2008;49(2):209\u201319.","journal-title":"ILAR J"},{"issue":"41","key":"9870_CR63","doi-asserted-by":"publisher","first-page":"eaau6298","DOI":"10.1126\/sciimmunol.aau6298","volume":"4","author":"M Sykes","year":"2019","unstructured":"Sykes M, Sachs DH. Transplanting organs from pigs to humans. Sci Immunol. 2019;4(41):eaau6298.","journal-title":"Sci Immunol"},{"issue":"12","key":"9870_CR64","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1097\/00007890-199606270-00004","volume":"61","author":"J Pirenne","year":"1996","unstructured":"Pirenne J, Benedetti E, Gruessner A, Moon C, Hakim N, Fryer JP, et al. Combined transplantation of small and large bowel. FK506 versus cyclosporine A in a porcine model. Transplantation. 1996;61(12):1685\u201394.","journal-title":"Transplantation"},{"issue":"2","key":"9870_CR65","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1097\/00007890-198802000-00005","volume":"45","author":"D Grant","year":"1988","unstructured":"Grant D, Duff J, Zhong R, Garcia B, Lipohar C, Keown P, et al. Successful intestinal transplantation in pigs treated with cyclosporine. Transplantation. 1988;45(2):279\u201384.","journal-title":"Transplantation"},{"issue":"4","key":"9870_CR66","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1159\/000444468","volume":"34","author":"HR Dalton","year":"2016","unstructured":"Dalton HR, Webb GW, Norton BC, Woolson KL, Hepatitis E, Virus. Time to change the textbooks. Digestive diseases. (Basel Switzerland). 2016;34(4):308\u201316.","journal-title":"(Basel Switzerland)"},{"issue":"27","key":"9870_CR67","doi-asserted-by":"publisher","first-page":"6914","DOI":"10.1073\/pnas.1705446114","volume":"114","author":"D Cao","year":"2017","unstructured":"Cao D, Cao QM, Subramaniam S, Yugo DM, Heffron CL, Rogers AJ, et al. Pig model mimicking chronic hepatitis E virus infection in immunocompromised patients to assess immune correlates during chronicity. Proc Natl Acad Sci U S A. 2017;114(27):6914\u201323.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"19","key":"9870_CR68","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.4254\/wjh.v7.i19.2194","volume":"7","author":"AR Murali","year":"2015","unstructured":"Murali AR, Kotwal V, Chawla S. Chronic hepatitis E: a brief review. World J Hepatol. 2015;7(19):2194\u2013201.","journal-title":"World J Hepatol"},{"issue":"2","key":"9870_CR69","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/gastro\/gox037","volume":"6","author":"A Singh","year":"2018","unstructured":"Singh A, Seth R, Gupta A, Shalimar, Nayak B, Acharya SK, et al. Chronic hepatitis E - an emerging disease in an immunocompromised host. Gastroenterol Rep. 2018;6(2):152\u20135.","journal-title":"Gastroenterol Rep"},{"issue":"3\u20134","key":"9870_CR70","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.vetmic.2009.03.017","volume":"140","author":"XJ Meng","year":"2010","unstructured":"Meng XJ, Hepatitis E. Virus: animal reservoirs and zoonotic risk. Vet Microbiol. 2010;140(3\u20134):256\u201365.","journal-title":"Vet Microbiol"},{"issue":"2","key":"9870_CR71","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1258\/002367778780953198","volume":"12","author":"IA Jacobsen","year":"1978","unstructured":"Jacobsen IA. Renal transplantation in the rabbit: a model for preservation studies. Lab Anim. 1978;12(2):63\u201370.","journal-title":"Lab Anim"},{"key":"9870_CR72","doi-asserted-by":"publisher","first-page":"691830","DOI":"10.1155\/2013\/691830","volume":"2013","author":"NA Kamaruzaman","year":"2013","unstructured":"Kamaruzaman NA, Kardia E, Kamaldin NA, Latahir AZ, Yahaya BH. The rabbit as a model for studying lung disease and stem cell therapy. Biomed Res Int. 2013;2013:691830.","journal-title":"Biomed Res Int"},{"issue":"3\u20134","key":"9870_CR73","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.vetimm.2007.11.011","volume":"122","author":"E Jeklova","year":"2008","unstructured":"Jeklova E, Leva L, Jaglic Z, Faldyna M. Dexamethasone-induced immunosuppression: a rabbit model. Vet Immunol Immunopathol. 2008;122(3\u20134):231\u201340.","journal-title":"Vet Immunol Immunopathol"},{"issue":"6563","key":"9870_CR74","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/379333a0","volume":"379","author":"D Graur","year":"1996","unstructured":"Graur D, Duret L, Gouy M. Phylogenetic position of the order Lagomorpha (rabbits, hares and allies). Nature. 1996;379(6563):333\u20135.","journal-title":"Nature"},{"issue":"2","key":"9870_CR75","doi-asserted-by":"publisher","first-page":"e9160","DOI":"10.1371\/journal.pone.0009160","volume":"5","author":"H Ma","year":"2010","unstructured":"Ma H, Zheng L, Liu Y, Zhao C, Harrison TJ, Ma Y, et al. Experimental infection of rabbits with rabbit and genotypes 1 and 4 hepatitis E viruses. PLoS ONE. 2010;5(2):e9160\u2013e.","journal-title":"PLoS ONE"},{"issue":"12","key":"9870_CR76","doi-asserted-by":"publisher","first-page":"e51616","DOI":"10.1371\/journal.pone.0051616","volume":"7","author":"X Cheng","year":"2012","unstructured":"Cheng X, Wang S, Dai X, Shi C, Wen Y, Zhu M, et al. Rabbit as a novel animal model for hepatitis E virus infection and vaccine evaluation. PLoS ONE. 2012;7(12):e51616\u2013e.","journal-title":"PLoS ONE"},{"issue":"4","key":"9870_CR77","doi-asserted-by":"publisher","first-page":"559","DOI":"10.3201\/eid1904.120827","volume":"19","author":"P Liu","year":"2013","unstructured":"Liu P, Bu QN, Wang L, Han J, Du RJ, Lei YX, et al. Transmission of hepatitis E virus from rabbits to cynomolgus macaques. Emerg Infect Dis. 2013;19(4):559\u201365.","journal-title":"Emerg Infect Dis"},{"issue":"6","key":"9870_CR78","doi-asserted-by":"publisher","first-page":"e99861","DOI":"10.1371\/journal.pone.0099861","volume":"9","author":"J Han","year":"2014","unstructured":"Han J, Lei Y, Liu L, Liu P, Xia J, Zhang Y, et al. SPF rabbits infected with rabbit hepatitis E virus isolate experimentally showing the chronicity of hepatitis. PLoS ONE. 2014;9(6):e99861.","journal-title":"PLoS ONE"},{"issue":"10","key":"9870_CR79","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1111\/jvh.12406","volume":"22","author":"J Xia","year":"2015","unstructured":"Xia J, Liu L, Wang L, Zhang Y, Zeng H, Liu P, et al. Experimental infection of pregnant rabbits with hepatitis E virus demonstrating high mortality and vertical transmission. J Viral Hepatitis. 2015;22(10):850\u20137.","journal-title":"J Viral Hepatitis"},{"issue":"5","key":"9870_CR80","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.pupt.2008.01.005","volume":"21","author":"S Keir","year":"2008","unstructured":"Keir S, Page C. The rabbit as a model to study asthma and other lung diseases. Pulm Pharmacol Ther. 2008;21(5):721\u201330.","journal-title":"Pulm Pharmacol Ther"},{"issue":"3","key":"9870_CR81","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1183\/09031936.94.07030555","volume":"7","author":"MH Karol","year":"1994","unstructured":"Karol MH. Animal models of occupational asthma. Eur Respir J. 1994;7(3):555\u201368.","journal-title":"Eur Respir J"},{"issue":"1","key":"9870_CR82","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/s12917-022-03337-x","volume":"18","author":"M Li","year":"2022","unstructured":"Li M, Wang Y, Li K, Lan H, Zhou C. Characterization of highly expressed novel hub genes in hepatitis E virus chronicity in rabbits: a bioinformatics and experimental analysis. BMC Vet Res. 2022;18(1):239.","journal-title":"BMC Vet Res"},{"issue":"Pt 10","key":"9870_CR83","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1099\/vir.0.068429-0","volume":"95","author":"DB Smith","year":"2014","unstructured":"Smith DB, Simmonds P, Members Of The International Committee On The Taxonomy Of Viruses, Study G, Jameel S, Emerson SU, Harrison TJ, et al. Consensus proposals for classification of the family Hepeviridae. J Gen Virol. 2014;95(Pt 10):2223\u201332.","journal-title":"J Gen Virol"},{"key":"9870_CR84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.vetmic.2017.05.019","volume":"207","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Gong W, Song WT, Fu H, Wang L, Li M, et al. Different susceptibility and pathogenesis of rabbit genotype 3 hepatitis E virus (HEV-3) and human HEV-3 (JRC-HE3) in SPF rabbits. Vet Microbiol. 2017;207:1\u20136.","journal-title":"Vet Microbiol"},{"issue":"3","key":"9870_CR85","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1002\/hep.32455","volume":"76","author":"Q He","year":"2022","unstructured":"He Q, Zhang F, Shu J, Li S, Liang Z, Du M, et al. Immunocompromised rabbit model of chronic HEV reveals liver fibrosis and distinct efficacy of different vaccination strategies. Hepatology (Baltimore MD). 2022;76(3):788\u2013802.","journal-title":"Hepatology (Baltimore MD)"},{"issue":"3","key":"9870_CR86","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1017\/S0016672300010168","volume":"8","author":"SP Flanagan","year":"1966","unstructured":"Flanagan SP. Nude\u2019, a new hairless gene with pleiotropic effects in the mouse. Genet Res. 1966;8(3):295\u2013309.","journal-title":"Genet Res"},{"issue":"5900","key":"9870_CR87","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/301527a0","volume":"301","author":"GC Bosma","year":"1983","unstructured":"Bosma GC, Custer RP, Bosma MJ. A severe combined immunodeficiency mutation in the mouse. Nature. 1983;301(5900):527\u201330.","journal-title":"Nature"},{"key":"9870_CR88","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/978-1-60761-688-7_27","volume":"640","author":"SC Strom","year":"2010","unstructured":"Strom SC, Davila J, Grompe M. Chimeric mice with humanized liver: tools for the study of drug metabolism, excretion, and toxicity. Methods Mol Biol. 2010;640:491\u2013509.","journal-title":"Methods Mol Biol"},{"issue":"1","key":"9870_CR89","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1177\/0300985811429314","volume":"49","author":"RS Sellers","year":"2012","unstructured":"Sellers RS, Clifford CB, Treuting PM, Brayton C. Immunological variation between inbred laboratory mouse strains: points to consider in phenotyping genetically immunomodified mice. Vet Pathol. 2012;49(1):32\u201343.","journal-title":"Vet Pathol"},{"issue":"5","key":"9870_CR90","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1136\/gutjnl-2015-311109","volume":"66","author":"IM Sayed","year":"2017","unstructured":"Sayed IM, Verhoye L, Cocquerel L, Abravanel F, Foquet L, Montpellier C, et al. Study of hepatitis E virus infection of genotype 1 and 3 in mice with humanised liver. Gut. 2017;66(5):920\u20139.","journal-title":"Gut"},{"issue":"3","key":"9870_CR91","doi-asserted-by":"publisher","first-page":"319","DOI":"10.3109\/08923979409007097","volume":"16","author":"W Budzynski","year":"1994","unstructured":"Budzynski W, Radzikowski C. Cytotoxic cells in immunodeficient athymic mice. Immunopharmacol Immunotoxicol. 1994;16(3):319\u201346.","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"9870_CR92","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0065-230X(08)60026-3","volume":"44","author":"BC Giovanella","year":"1985","unstructured":"Giovanella BC, Fogh J. The nude mouse in cancer research. Adv Cancer Res. 1985;44:69\u2013120.","journal-title":"Adv Cancer Res"},{"issue":"6982","key":"9870_CR93","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/nature02426","volume":"428","author":"RA Gibbs","year":"2004","unstructured":"Gibbs RA, Weinstock GM, Metzker ML, Muzny DM, Sodergren EJ, Scherer S, et al. Genome sequence of the Brown Norway rat yields insights into mammalian evolution. Nature. 2004;428(6982):493\u2013521.","journal-title":"Nature"},{"issue":"0","key":"9870_CR94","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.neuropharm.2013.05.047","volume":"76","author":"CC Parker","year":"2014","unstructured":"Parker CC, Chen H, Flagel SB, Geurts AM, Richards JB, Robinson TE, et al. Rats are the smart choice: Rationale for a renewed focus on rats in behavioral genetics. Neuropharmacology. 2014;76(0):250\u20138. Pt B(0.","journal-title":"Neuropharmacology"},{"issue":"6","key":"9870_CR95","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1111\/j.1067-1927.2004.12601.x","volume":"12","author":"WA Dorsett-Martin","year":"2004","unstructured":"Dorsett-Martin WA. Rat models of skin wound healing: a review. Wound Repair Regeneration. 2004;12(6):591\u20139.","journal-title":"Wound Repair Regeneration"},{"key":"9870_CR96","doi-asserted-by":"crossref","unstructured":"Zhang W, Ami Y, Suzaki Y, Doan YH, Muramatsu M, Li TC. Mongolia Gerbils are broadly susceptible to Hepatitis E Virus. Viruses. 2022;14(6).","DOI":"10.3390\/v14061125"},{"issue":"7700","key":"9870_CR97","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/s41586-018-0012-7","volume":"556","author":"M Shi","year":"2018","unstructured":"Shi M, Lin XD, Chen X, Tian JH, Chen LJ, Li K, et al. The evolutionary history of vertebrate RNA viruses. Nature. 2018;556(7700):197\u2013202.","journal-title":"Nature"},{"key":"9870_CR98","doi-asserted-by":"crossref","unstructured":"Liu T, He Q, Yang X, Li Y, Yuan D, Lu Q et al. An Immunocompetent Mongolian Gerbil Model for Hepatitis E Virus genotype 1 infection. Gastroenterology. 2024.","DOI":"10.1053\/j.gastro.2024.03.038"},{"issue":"24","key":"9870_CR99","doi-asserted-by":"publisher","first-page":"e2201862119","DOI":"10.1073\/pnas.2201862119","volume":"119","author":"D Tian","year":"2022","unstructured":"Tian D, Li W, Heffron CL, Wang B, Mahsoub HM, Sooryanarain H, et al. Hepatitis E virus infects brain microvascular endothelial cells, crosses the blood-brain barrier, and invades the central nervous system. Proc Natl Acad Sci U S A. 2022;119(24):e2201862119.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"9870_CR100","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jhep.2020.12.030","volume":"75","author":"T Horvatits","year":"2021","unstructured":"Horvatits T, Wi\u00dfmann JE, Johne R, Groschup MH, Gadicherla AK, Schulze Zur Wiesch J, et al. Hepatitis E virus persists in the ejaculate of chronically infected men. J Hepatol. 2021;75(1):55\u201363.","journal-title":"J Hepatol"},{"issue":"5","key":"9870_CR101","doi-asserted-by":"publisher","first-page":"e1012240","DOI":"10.1371\/journal.ppat.1012240","volume":"20","author":"KK Yadav","year":"2024","unstructured":"Yadav KK, Boley PA, Laocharoensuk T, Khatiwada S, Lee CM, Bhandari M, et al. Infectious hepatitis E virus is associated with the mature sperm head. PLoS Pathog. 2024;20(5):e1012240.","journal-title":"PLoS Pathog"},{"issue":"6","key":"9870_CR102","doi-asserted-by":"publisher","first-page":"e29735","DOI":"10.1002\/jmv.29735","volume":"96","author":"M Schemmerer","year":"2024","unstructured":"Schemmerer M, Bock HH, Schattenberg JM, Huber S, Polywka S, Mader M, et al. Proof of infectivity of hepatitis E virus particles from the ejaculate of chronically infected patients. J Med Virol. 2024;96(6):e29735.","journal-title":"J Med Virol"},{"issue":"1","key":"9870_CR103","doi-asserted-by":"publisher","first-page":"103720","DOI":"10.1016\/j.bjid.2024.103720","volume":"28","author":"G Sch\u00e4fer","year":"2024","unstructured":"Sch\u00e4fer G, L\u00fcbke R, Degen O, Mader M, Scheiter R, Wolski A, et al. Lack of evidence of acute HEV infections as a sexually transmitted disease: data from a German cohort of PrEP users. Brazilian J Infect Diseases: Official Publication Brazilian Soc Infect Dis. 2024;28(1):103720.","journal-title":"Brazilian J Infect Diseases: Official Publication Brazilian Soc Infect Dis"},{"key":"9870_CR104","doi-asserted-by":"crossref","unstructured":"Chaix ML, Leturque N, Gabassi A, Charreau I, Minier M, Pialoux G et al. Prevalence and incidence of HEV among men using HIV pre-exposure prophylaxis: a sub-study of the ANRS IPERGAY trial. Journal of clinical virology: the official publication of the Pan American Society for Clinical Virology. 2023;160:105380.","DOI":"10.1016\/j.jcv.2023.105380"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-09870-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-024-09870-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-09870-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T19:02:35Z","timestamp":1726167755000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-024-09870-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,12]]},"references-count":104,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["9870"],"URL":"https:\/\/doi.org\/10.1186\/s12879-024-09870-4","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,12]]},"assertion":[{"value":"31 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"KKY has 6 years of experience working with HEV and has utilized the immunosuppressed pig animal model to understand the pathology of HEV ribavirin resistant mutant viruses. SPK has more than 14 years of experience working with HEV and has been awarded by the National Institute of Health (NIH) to study the pathogenesis of ribavirin resistant mutants in an immunosuppressed pig model. KKY and SPK have experiences with various animal models including but not limited to pigs, chickens, turkeys, rabbits, ferrets, mice, and hamsters.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors information"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"965"}}